Inhibition of p53‐dependent transcription by BOX‐I phospho‐peptide mimetics that bind to p300
Open Access
- 1 February 2001
- journal article
- research article
- Published by Springer Nature in EMBO Reports
- Vol. 2 (2) , 139-144
- https://doi.org/10.1093/embo-reports/kve025
Abstract
The N‐terminal BOX‐I domain of p53 containing a docking site for the negative regulator MDM2 and the positive effector p300, harbours two recently identified phosphorylation sites at Thr18 or Ser20 whose affect on p300 is undefined. Biochemical assays demonstrate that although MDM2 binding is inhibited by these phosphorylations, p300 binding is strikingly stabilized by Thr18 or Ser20 phosphorylation. Introducing EGFP‐BOX‐I domain peptides with an aspartate substitution at Thr18 or Ser20 induced a significant inhibition of endogenous p53‐dependent transcription in cycling cells, in irradiated cells, as well as in cells transiently co‐transfected with p300 and p53. In contrast an EGFP‐wild‐type BOX‐I domain peptide stimulated p53 activity via inhibition of MDM2 protein binding. These results suggest that phosphorylation of p53 at Thr18 or Ser20 can activate p53 by stabilizing the p300–p53 complex and also identify a class of small molecular weight ligands capable of selective discrimination between MDM2‐ and p300‐dependent activities.Keywords
This publication has 22 references indexed in Scilit:
- CBP/p300 in cell growth, transformation, and developmentGenes & Development, 2000
- Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like KinaseJournal of Biological Chemistry, 2000
- Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2The EMBO Journal, 1999
- Dephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiationOncogene, 1999
- Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancersBiochemical Journal, 1999
- Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancersBiochemical Journal, 1999
- Protein Interaction Methods-Toward an EndgameScience, 1999
- Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2The EMBO Journal, 1999
- Phosphorylation of p53 Serine 15 Increases Interaction with CBPJournal of Biological Chemistry, 1998
- Mdm2 promotes the rapid degradation of p53Nature, 1997